• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus
Product CodeMZP
Regulation Number 866.3170
Device Class 2


Premarket Reviews
ManufacturerDecision
ROCHE MOLECULAR SYSTEMS, INC.
  SUBSTANTIALLY EQUIVALENT 1

Premarket Approvals (PMA)
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
11 19 20 17 24 12 12 21 15 30 35 18 8 0 0 0

MDR Year MDR Reports MDR Events
2014 13 13
2015 1 1
2016 12 12
2017 5 5
2018 4 4
2019 5 5
2020 1 1
2021 1 1
2022 1 1
2023 1 1

Device Problems MDRs with this Device Problem Events in those MDRs
Incorrect, Inadequate or Imprecise Result or Readings 18 18
Incorrect Or Inadequate Test Results 8 8
False Negative Result 6 6
Low Test Results 4 4
False Positive Result 3 3
Off-Label Use 3 3
False Reading From Device Non-Compliance 2 2
Unable to Obtain Readings 1 1
Output Problem 1 1
Data Problem 1 1
Unexpected Therapeutic Results 1 1
Use of Device Problem 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Known Impact Or Consequence To Patient 24 24
No Consequences Or Impact To Patient 8 8
No Information 3 3
No Clinical Signs, Symptoms or Conditions 2 2
Test Result 2 2
Death 2 2
Dyspnea 1 1
Exsanguination 1 1
Unspecified Infection 1 1
Therapeutic Effects, Unexpected 1 1
Complaint, Ill-Defined 1 1
Chemical Exposure 1 1

Recalls
Manufacturer Recall Class Date Posted
1 Abbott Molecular, Inc. II Nov-29-2023
2 Abbott Molecular, Inc. II Aug-12-2022
3 Abbott Molecular, Inc. II Jan-06-2022
4 Abbott Molecular, Inc. II Jan-06-2022
5 Abbott Molecular, Inc. II Jan-06-2022
6 Abbott Molecular, Inc. II Jan-06-2022
7 Roche Molecular Systems, Inc. II Jun-17-2011
-
-